Nicholas Yulico's questions to American Healthcare REIT (AHR) leadership • Q2 2025
Question
Nicholas Yulico from Scotiabank asked about the implied deceleration in Trilogy's same-store NOI growth guidance for the second half of the year. He also inquired about the drivers behind the lower interest expense guidance and the planned funding mix for future investments.
Answer
CFO Brian Peay and President & CEO Danny Prosky attributed the implied slowdown to significantly tougher year-over-year comps from Q3 and Q4 2024, along with minor seasonal headwinds. Regarding funding, Brian Peay confirmed that lower interest expense guidance resulted from paying down debt with equity raised via the ATM program. He stated future investments will be funded through a combination of retained earnings, potential ATM usage, and capacity on the revolving credit facility.